If you thought only cars could be autonomous (hey, Tesla), think again. Medical device company Control Bionics (ASX: CBL) has wheeled the technology into autonomous wheelchairs, ensuring people with Amyotrophic Lateral Sclerosis (ALS)—a motor neuron disease—live a better, “freer” life. In support of that, the Company’s wholly-owned US subsidiary has secured a research grant of
Read More
Good things come in small packages, like PharmAust’s (ASX: PAA) newest iteration of their monepantel (MPL) tablets. The clinical stage biotechnology company has manufactured smaller versions of their lead asset, MPL, a potent small molecule drug that has been shown to affect key pathways associated with cancer and other diseases. PharmAust have studied MPL for
Read More
Technology company, Control Bionics Limited (Proposed ASX: CBL) are one of the latest medtech companies looking to list on the exchange next month. The company is looking to raise $15m by November 25 at an offer price of $0.60 per share, giving the company an indicative market capitalization at the offer price of $50m. The
Read More